TT-01025

N/A

Report date: 2022/04/29 16:00:35
NME

Base Information

Drug NameTT-01025
Drug Alias NameTT-01025-CLLG-00303174LR-20056
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTransThera Sciences (Nanjing) Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLG Chem Life Sciences Innovation Center IncLg Chemical LtdTransThera Sciences (Nanjing) Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A